Humidity control can compensate for the damage induced in protein crystals by alien solutions by Abad-Zapatero, Cele & Guasch, Alicia
laboratory communications
1300 doi:10.1107/S174430911103377X Acta Cryst. (2011). F67, 1300–1308
Acta Crystallographica Section F
Structural Biology
and Crystallization
Communications
ISSN 1744-3091
Humidity control can compensate for the damage
induced in protein crystals by alien solutions
C. Abad-Zapatero,a,b*
R. Oliete,a,c S. Rodriguez-
Puente,a,c J. Pous,a,d
L. Martinelli,d M. E. Johnsonb and
A. Guascha,c,e*
aPlataforma Automatitzada de Cristallografia,
Barcelona, Spain, bCenter for Pharmaceutical
Biotechnology, University of Illinois at Chicago,
Chicago, Illinois, USA, cParc Cientı´fic de
Barcelona, Barcelona, Spain, dInstitute for
Research in Biomedicine, Barcelona, Spain, and
eInstitut de Biologia Molecular de Barcelona–
CSIC, Barcelona, Spain
Correspondence e-mail: caz@uic.edu,
aguasch@pcb.ub.cat
Received 27 June 2011
Accepted 18 August 2011
The use of relative humidity control of protein crystals to overcome some of the
shortcomings of soaking ligands (i.e. inhibitors, substrate analogs, weak ligands)
into pre-grown apoprotein crystals has been explored. Crystals of PurE (EC
4.1.1.21), an enzyme from the purine-biosynthesis pathway of Bacillus anthracis,
were used as a test case. The findings can be summarized as follows: (i) using
humidity control, it is possible to improve/optimize the diffraction quality of
crystals soaked in solutions of organic solvent (DMSO, ethanol) containing
ligands/inhibitors; (ii) optimization of the relative humidity can compensate for
the deterioration of the diffraction pattern that is observed upon desalting
crystals grown in high salt; (iii) combining desalting protocols with the addition
of PEG it is possible to achieve very high concentrations of weak ligands (in
the 5–10 mM range) in soaking solutions and (iv) fine control of the relative
humidity of crystals soaked in these solutions can compensate for the
deterioration of crystal diffraction and restore ‘high-resolution’ diffraction for
structure-based and fragment-based drug design. It is suggested that these
experimental protocols may be useful in other protein systems and may be
applicable in academic or private research to increase the probability of
obtaining structures of protein–ligand complexes at high resolution.
1. Introduction
The notion and observation that the diffraction pattern of protein
crystals changes with the humidity of the medium surrounding the
crystals dates back to the first diffraction of protein crystals by Bernal
& Crowfoot (1934) and was a crucial insight for the development of
the field (Abad-Zapatero, 2005). It was also systematically studied by
Perutz in his early attempts to solve the phase problem by studying
the shrinkage of hemoglobin crystals in different salt solutions
(Perutz, 1946). In recent years, the availability of devices that permit
fine control of the relative humidity of the crystals [free-mounting
systems (FMS) or humidity-control (HC) devices; Kiefersauer et al.,
2000; Sanchez-Weatherby et al., 2009] has made it possible to improve
the resolution (in some cases dramatically) of protein crystals whose
diffraction properties were suboptimal. The current status of these
developments in macromolecular crystallography have recently been
reviewed (Russi et al., 2011), particularly in relation to the method-
ology used in fragment-based approaches to the discovery of lead
compounds (Bo¨ttcher et al., 2011).
Critical to any structure-based drug-design (SBDD) effort, and
more so for fragment-based approaches (FBDD), is the availability
of large numbers of target–ligand (target–fragment) complexes that
can be used to validate the initial ‘hits’ or to optimize valuable lead
compounds by medicinal chemistry efforts. Yet, it is a common
observation that well diffracting protein crystals deteriorate signifi-
cantly and often also rapidly upon soaking with concentrated solu-
tions of the fragment or ligand compounds typically dissolved in
dimethyl sulfoxide (DMSO).
In addition, fragment-based approaches for drug discovery and
even conventional SBDD protocols quite often encounter difficulties
in introducing ligands either by soaking or cocrystallization of low-
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affinity compounds. During the soaking process, this is often because
the active sites of the targets of interest are occupied by salts, addi-
tives or other chemicals that preclude or prevent successful soaking
of target–ligand complexes (Bo¨ttcher et al., 2011). Although it might
appear that cocrystallization can address this problem, most of the
time this is not the case because the ligands typically have weak
affinity (in the 10–100 mM range) and have to compete with the
presence of high concentrations of salts (>0.5M) that are required to
crystallize the proteins. Thus, even in cocrystallization experiments
the putative target–ligand complexes do not result in satisfactory
crystallization outcomes. Research groups trying to soak/cocrystallize
substrate analogs, cofactors and other compounds of interest in order
to study enzymatic mechanisms often encounter similar problems.
The purpose of the work described here was to test whether fine
control of the relative humidity of the crystals could be used to
address some of the above issues and limitations. In practical terms,
we wanted to establish experimental protocols that would increase
the positive outcome of experiments designed to introduce ligands
into pre-grown apoenzyme crystals. The experiments were designed
to (i) recover the quality of the diffraction pattern of the crystals after
ligand soaking, (ii) diminish the presence of salts (or other interfering
chemicals) in the active sites of proteins to facilitate the binding of
weak ligands and (iii) maximize the effective concentration of weak
ligands in the soaking solutions to facilitate the validation of
fragment-based approaches.
In addition, we systematically explored crystallization protocols
under low-salt conditions, beyond the optimized initial screens, in an
attempt to find different crystal forms or other favorable conditions
that would be more amenable to successful soaking experiments. For
this purpose, we used systematic searches in ‘protein crystallization
space’, also called ‘phase diagrams’ (Saridakis et al., 1994) or in more
practical terms referred to as ‘precipitation diagrams’ (Saijo et al.,
2005).
As a test system, we used protein crystals of PurE (EC 4.1.1.21),
a critical enzyme of the purine-biosynthetic pathway in Bacillus
anthracis (Samant et al., 2008). The structure of this enzyme
expressed in Escherichia coli has been solved (Mathews et al., 1999) at
1.5 A˚ resolution (PDB entry 1qcz) as well as that of a PurE–mono-
nucleotide complex (PDB entry 1d7a), and a high-resolution (1.8 A˚)
structure of PurE from B. anthracis has also been reported (Boyle et
al., 2005; PDB entry 1xmp). Owing to its critical role in the growth
of bacteria in human blood (Samant et al., 2008), the structures of
enzymes from the purine-biosynthesis pathway have been extensively
studied (Zhang et al., 2008) and the three-dimensional structures of
PurE from several important pathogens have recently been reported
(PDB entries 3rg8, 3rgg, 3oow, 3lp6, 3kuu and 3k5h; Tranchimand
et al., 2011; Thoden et al., 2010). The crystal forms that we have
obtained for the PurE from B. anthracis have not been reported to
date and we have described and characterized these novel crystal
forms as a demonstration of the importance of searching system-
atically in protein-crystallization space.
Our results with this enzyme system suggest that it is possible to
compensate for the damage induced in protein crystals by extraneous
(non-mother-liquor) solutions by suitable adjustment of the relative
humidity. Whether or not these initial results can be extended or
generalized to other protein systems remains an open question. If
confirmed, these results could have application in the more successful
preparation of crystalline protein–ligand complexes for enzymatic
and structural studies in academic laboratories or in the pharma-
ceutical industry.
2. Materials and methods
2.1. Sample preparation
2.1.1. Protein expression. A plasmid with the gene encoding PurE
(Q81ZH8) from B. anthracis with an N-terminus with the sequence
MGSSHHHHHHSSGLVPRGSH was prepared by the group at the
University of Illinois at Chicago (UIC) as part of a collaborative
agreement. The corresponding molecular weight for this plasmid is
19 205 Da.
E. coli BL21 transformant cells were cultured at 310 K in 500 ml
TB (Terrific Broth) medium containing 500 ml ampicillin
(100 mg ml1) and shaken (160 rev min1) for 2–3 h to an OD600 nm of
0.6–0.7, at which point expression was induced by 1 mM isopropyl -
d-1-thiogalactopyranoside (IPTG). The cells were grown for an
additional 4–5 h at 310 K, after which they were recovered by
centrifugation.
2.1.2. Protein purification. An initial purification protocol was
provided by the group at UIC and was subsequently optimized. The
cells were resuspended in 50 mM Tris–HCl pH 8.0, 500 mM NaCl,
10 mM imidazole, one protease-inhibitor cocktail tablet, 1 mg ml1
lysozyme, 1% Triton-X and lysed by ultrasonication followed by
centrifugation to obtain a soluble fraction. The soluble fraction was
loaded onto a nickel immobilized metal-affinity column (HisTrap HP,
GE Healthcare) and the protein was eluted using an imidazole
gradient from 10 to 500 mM in 500 mM NaCl, 50 mM Tris–HCl
pH 8.0.
Further purification was carried out using a Superdex 200 HiLoad
26/60 size-exclusion column which was equilibrated at 0.2 ml min1
with two different ionic buffers: high salt (200 mM NaCl, 0.05M Tris
pH 7.5) and low salt (50 mM NaCl, 0.05M Tris pH 7.5). The two
different protein salt concentrations were kept separated and are
referred to as HS and LS. The protein was eluted as a unique peak
that corresponded to 158 000 Da. The pure protein was kept at 277 K
for short periods.
2.1.3. Protein crystallization. Initial crystallization conditions were
identified by robot-assisted vapor-diffusion experiments using sparse-
matrix screens. Experiments were performed mixing crystallization
condition and sample in a 1:1 ratio to give a final volume of 200 nl.
Around 1000 conditions were tested and crystals grew under four
conditions at a temperature of 293 K. These conditions were subse-
quently scaled up and optimized at 293 K in 24-well Cryschem plates
(Hampton Research, USA). The conditions were A (0.1M cacody-
late pH 6.5, 0.75M sodium acetate), which was called the ‘salt’
condition, B (0.1M Tris pH 8.5, 15% PEG 4000, 0.3M sodium
acetate), C (0.1M Tris pH 7.5, 15% PEG 4000, 0.8M sodium
formate) and D (0.1M Tris pH 7.5, 10% PEG 1000, 10% PEG 8000,
0.8M sodium formate). The three latter conditions were called ‘salt +
PEG’ conditions. Form E was found much later after exploring a wide
range of salt and protein concentrations through the protein
precipitation diagram. The details are summarized for convenience in
Table 1 and the crystallographic parameters, packing ratios and data-
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Table 1
Crystallization conditions for the different crystal forms of PurE presented in this
work.
Crystal form Buffer Salt PEG
A 0.1M cacodylate pH 6.5 0.75M sodium acetate —
B 0.1M Tris pH 8.5 0.3M sodium acetate 15% 4K
C 0.1M Tris pH 7.5 0.8M sodium formate 15% 4K
D 0.1M Tris pH 7.5 0.8M sodium formate 10% 1K, 10% 8K
E 0.1M cacodylate pH 6.5 0.3–0.4M sodium acetate —
collection statistics of the different crystal forms are presented in
Table 2.
2.1.4. Exploration of the precipitation diagram. A program was
designed to explore the precipitation diagram of PurE using a
nanolitre-handling dispensing device. Phase-diagram experiments
for the successful crystallization conditions were performed using a
Cartesian Dispensing System (Genomic Solutions, UK). The program
was designed for 96-well MRC plates (Swissci, Switzerland). The
experiments were designed as follows. Firstly, the protein was
dispensed into the plate, decreasing the volume along each row. The
protein buffer was then added above the sample in order to reach the
same volume for each well. The concentration of the precipitant
increased from left to right. An example plate is shown in Fig. 1. In
form A the sodium acetate range varied between 0.2 and 0.6M. In
forms C and D the sodium formate ranges were between 0.005 and
1.2M, keeping the PEG concentration constant, while the concen-
tration of PEG varied between 15 and 21%, keeping the sodium
formate concentration constant. In all forms (A, B, C and D) pH
variation (5.4–8.5) was performed following the same protocol.
2.1.5. Soaking of protein crystals. Standard soaking protocols were
as follows. 1 ml of a concentrated stock solution (100 mM) of the
ligand (most commonly in DMSO) was mixed with 19 ml of the crystal
mother liquor. This protocol limits the exposure of the protein
crystals to the damaging effect of DMSO (5%) and maximizes the
exposure of the protein crystal to the ligand (5 mM). The affinity of
the ligands (i.e. substrate analogs, inhibitors and fragment libraries)
could be in the micromolar range but would certainly be weaker if
the soaking ligands were small fragments. Typical soaking times can
range from a few (4–6) hours to overnight (1 ovn; 14–16 h) or longer
soaks (2 ovn; ‘two overnights’, 28–32 h). Longer soaks maximize the
exposure of the crystals to the ligands but result in damage to the
crystals, which lose their diffraction qualities. Soaking experiments
that maximize the ligand exposure under very low salt concentrations
are described below.
2.1.6. Sequential desalting protocols. Specific protocols were
designed in order to maximize the ligand concentration in the solu-
tion while at the same time minimizing the presence of salt in the
mother liquor. Sequentially, the salt concentration was decreased
in the crystal while the PEG concentration was increased and at the
same time a high-concentration solution of the ligand in ethanol
or DMSO was introduced. Five different harvesting solutions, with
variations in salt, PEG and ligand, were prepared. The protocols are
listed in Table 3 and summarized pictorially in Fig. 2.
2.2. Data collection and crystallographic analysis of different crystal
forms
2.2.1. Rotating anode. The crystals grew to full size in approxi-
mately one week and were transferred to cryoprotection buffer
with an added or increased PEG concentration and flash-cooled
in micromounts (MiTeGen, Ithaca, USA). Native X-ray diffraction
data were collected from a single crystal at 100 K using a MAR 345
detector coupled to a Rigaku MicroMax-007 rotating-anode X-ray
generator (Cu K radiation) operating at 40 kV and 20 mA and
equipped with Osmic confocal focusing optics (Rigaku–MSC, Texas,
USA). For room-temperature data collection (295 K), 90 frames of
data were collected using an oscillation angle of 1, a crystal-to-
detector distance of 200 mm and 5 min exposure time.
2.2.2. Synchrotron data collection. Following the different soaking
protocols, the relative humidity was optimized by examining the
extent and quality of the diffraction pattern visually. At the optimal
diffraction pattern, room-temperature data sets were collected,
typically using 1 oscillation and exposure times ranging from 0.1 to
0.5 s for a maximum of 120. In addition, in certain cases and for
certain conditions crystals were frozen at the optimal relative
laboratory communications
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Figure 1
Precipitation diagram of PurE protein (form A) versus salt concentration. The
symbols were assigned by the appearance of nuclei (N), crystals (C) and clear drops
(S). In order to attempt a quantitative assessment, two additional codes were
assigned (CX–Y). X: 1–10 for number of crystals. Y: 1–10 for quality, 10 being the
best.
Table 2
Unit-cell parameters and data-collection statistics for the different crystal forms of PurE presented in this work.
Values in parentheses are for the last resolution shell.
Crystal
form
Space
group
Unit-cell parameters
(A˚, )
Rmerge
(%)
Completeness
(%) Beamline hI/(I)i Multiplicity
No. of
unique
reflections
Resolution
limits (A˚)
Matthew
coefficient
(A˚3 Da1)
Solvent
content
(%) AU†
A P3121 a = b = 86.86, c = 131.37 5.4 (32.0) 99.9 (99.9) ESRF ID14-1 29.2 (7.2) 10.9 (10.4) 57662 28.5–1.76 (1.80–1.76) 1.86 33.92 4
B P6522 a = b = 87.00, c = 270.00 7.1 (31.0) 96.6 (94.1) ESRF ID14-2 32.7 (5.8) 8.1 (6.0) 42925 50–1.95 (2.05–1.95) 1.92 35.93 4
C P6522 a = b = 88.20, c = 275.26 7.0 (47.5) 72.5 (50.4) Rigaku MicroMax-007 16.5 (1.9) 3.1 (1.9) 9821 50–3.00 (3.10–3.00)‡ 2.01 38.84 4
D P6522 a = b = 87.12, c = 269.15 8.1 (17.1) 98.6 (92.0) Rigaku MicroMax-007 39.0 (13.3) 9.1 (8.6) 12902 50–2.99 (3.10–2.99)‡ 1.92 35.90 4
E C2 a = 87.56, b = 151.90,
c = 134.85,  = 98.33
7.3 (43.4) 93.4 (89.5) ESRF ID14-2 38.2 (8.9) 5.1 (5.2) 56146 50–2.50 (2.56–2.50) 1.92 36.08 12
† Number of chains in the asymmetric unit. 4 refers to a full tetramer and 12 corresponds to a full octamer and an additional tetramer in the monoclinic C2 cell. ‡ Data collection in-
house using a rotating anode at room temperature; all other data were collected on the ESRF synchrotron beamlines under cryoconditions after the crystals had been adjusted to the
optimal r.h. and frozen by dismounting as described in x2.
humidity by dismounting them into the standard sample exchangers.
Full data sets at high resolution were subsquently collected on
different beamlines when time was available. X-ray data were
collected for the apoenzyme and different soaking experiments on
beamlines ID14-1 ( = 0.9340 A˚), ID14-2 ( = 0.9330 A˚), ID23-1
( = 0.9792 A˚) and BM14 ( = 0.97625 A˚) at the ESRF. Details are
provided in Table 2.
2.2.3. Humidity-control devices. Two different devices were used
to control the relative humidity in two separate installations. Firstly,
the original system design referred to as a free-mounting system
(FMS; Kiefersauer et al., 2000) was used. This instrument achieves
dehydration by two airstreams of 0% and 100% relative humidity
(r.h.) that are mixed giving the desired r.h. A feedback mechanism
based on dew-point measurement is used to determine the actual r.h.,
which depends on the temperature of the sample. Variations in r.h.
are achieved by software control of the two independent streams.
The device was adapted and installed in an in-house Rigaku X-ray
generator as presented above.
The second device, described as a humidity-control (HC) device, is
based on the nozzle of a standard cryostream (Sanchez-Weatherby et
al., 2009) and can be rapidly and easily installed on different beam-
lines if they are already equipped with the appropriate mounting. The
experimental protocols varying the r.h. were performed on the ESRF
synchrotron-radiation beamline BM14, but the unit is easily trans-
portable to other beamlines (i.e. ID23-1). The data sets collected
on BM14 used a wavelength of 0.97625 A˚. Conveniently, once the
optimal relative humidity has been obtained, the crystals can be
frozen by dismounting them into a standard sample exchanger for
future data collection at 100 K. These protocols were used on ESRF
beamlines ID14-1, ID14-2 and ID23-1 for the collection of full data
sets under cryoconditions.
2.2.4. Data processing. Indexing and characterization of the
different crystal forms was performed with the interactive iMOSFLM
package (Battye et al., 2011) using the automatic indexing routine.
Selection of the most suitable unit-cell parameters and crystallo-
graphic symmetry was performed by selecting the parameters
corresponding to the highest possible symmetry and lowest possible
penalty. Similar strategies were used when the data were processed
with HKL-2000 (Otwinowski & Minor, 1997).
2.2.5. Structure solution and refinement. The structures of PurE
in high-symmetry forms (hexagonal and trigonal) diffracting to high
resolution (forms A and B) were solved by molecular replacement
using the coordinates of B. anthracis PurE (PDB entry 1xmp) as a
search model after removing all solvent atoms. Molecular replace-
ment was performed using MOLREP (Lebedev et al., 2008; Vagin &
Teplyakov, 2011) from the CCP4 (Winn et al., 2011) suite of programs.
Cross-rotation and translational searches for one tetramer in the
asymmetric unit (subunitsA–D) were performed with data from 15 to
3.0 A˚ resolution, followed by rigid-body refinement with REFMAC5
(Murshudov et al., 2011). The model was rebuilt manually using
A-weighted 2mFoDFc andmFoDFc electron-density maps with
the Coot (Emsley & Cowtan, 2004) molecular-graphics program while
gradually introducing higher resolution reflections up to the resolu-
tion limit. An initial set of water molecules were located with Coot
laboratory communications
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Table 3
Details of the soaking protocols of apo PurE crystals for desalting and optimization
of ligand concentration.
(a) Form D soaking protocols.
Solution
No.
Tris pH 7.5
(M)
PEG 8K
[%(w/v)]
PEG 1K
[%(w/v)]
Sodium
formate
(M)
L3† compound
(mM)
Soaking
time
1 0.1 12 10 0.40 No 15 min
2 0.1 14 10 0.20 No 15 min
3 0.1 16 10 0.05 7.45 15 min
4 0.1 18 10 0.01 14.90 15 min
5 0.1 20 10 0 29.81 1 or 2 ovn
(b) Form C soaking protocols.
Solution
No.
Tris pH 7.5
(M)
PEG 4K
[%(w/v)]
Sodium formate
(M)
L1† compound
(mM)
Soaking
time
1 0.1 17 0.4 No 15 min
2 0.1 19 0.2 No 15 min
3 0.1 21 0.05 2.89 15 min
4 0.1 23 0.01 5.78 15 min
5 0.1 25 0 11.56 1 or 2 ovn
† L1 and L3 refer to small fragments in the ActiveSight library. The final concentration
of the ligands depends on the solubility of the ligands. Initial conditions (‘mother liquor’)
are as indicated in Table 1 for the corresponding forms.
Figure 2
Pictorial summary of the soaking protocols. The diagram illustrates the steps suggested for changing the initial mother liquor of the crystal to a solution containing no salt and
a high concentration of the ligand. B is the original buffer solution. P denotes the concentration of two different PEGs, one of which (PEG 8K) changes progressively from 12
to 20%. The concentration of PEG 1K remains constant at 10%(w/v). S denotes the salt solution, which changes from the initial 0.4M sodium formate to 0.0M (see Tables 1
and 3 for crystallization conditions versus soaking protocols). A indicates the solution containing the ligand at the corresponding percentage (v/v) to a final concentration of
29.81 mM. The solvent for the ligand can be DMSO or ethanol.
and were refined with REFMAC5 (Murshudov et al., 2011). The
current refinement statistics for these two forms are Rwork = 0.183,
Rfree = 0.231 (P3121) and Rwork = 0.173, Rfree = 0.214 (P6522).
The monoclinic C2 crystal form (form E) was solved using a similar
strategy and a definitive solution was found with three independent
tetramers in the asymmetric unit. This solution was later reconfigured
to a full octamer in a general position and a tetramer near a
crystallographic twofold. This structure has also been partially refined
using the same strategy as above and the current refinement statistics
are Rwork = 0.173 and Rfree = 0.250. Exhaustive refinement of the
solvent structures in the three forms is continuing.
3. Results and discussion
Initial crystallographic screens yielded two basic crystal forms:
hexagonal (P6522) and trigonal (P3121) (Table 2). The hexagonal
form was the predominant form under various different conditions,
but none of these crystal forms have previously been characterized
for PurE from B. anthracis. The trigonal form was unique in that it
only grew in the presence of high salt (0.75M sodium acetate)
without PEG. The type A crystals belonged to the trigonal space
group P3121, with unit-cell parameters a = b = 88.9, c = 133.4 A˚.
The crystals of forms B, C and D were all hexagonal and belonged
to space group P6522, with unit-cell parameters of approximately
a = b = 87.4, c = 276.0 A˚. Although grown using different precipitant
salts (sodium acetate versus sodium formate) and at different
concentrations (0.3 versus 0.8M) and different pHs (8.5 versus 7.5),
these three forms appeared to be isomorphous based on their closely
similar unit-cell parameters, particularly forms B and D. A summary
of the various crystal forms characterized and analyzed in this study is
presented in Table 2. Interestingly, the unit-cell volume of the
hexagonal form is approximately double that of the trigonal form.
This dramatic change is achieved by approximately doubling the
c axis while retaining the same dimensions for the shorter axes
(a = b ’ 88 A˚). The unit-cell parameters of the C2 cell correspond
approximately to a re-indexing of the trigonal cell with the C222
equivalent orthorhombic cell of dimensions a = 88, b = 152.4,
c = 132 A˚ after changing the orthogonal angle of the cell to  = 98.33
for the monoclinic cell. This observation suggests that the crystal
packings of the different crystal forms are related (see below).
Previous work revealed that the structure of the enzyme from
B. anthracis was an octamer exhibiting 422 symmetry (Boyle et al.,
2005). The octamer also crystallized in a C2 cell and the crystal
contained a full octamer in the asymmetric unit. Structure solution of
the forms diffracting to high resolution (forms A, B and E; see x2)
laboratory communications
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Figure 3
Self-rotation functions of the three different crystal forms of PurE. The top panels (left to right) present the planes for twofolds ( = 180) for the three different forms
(P6522, P3121 and C2, respectively). The lower panels depict the planes for the orientation of the fourfold of the PurE octameric aggregate (left;  = 90
) in the P6522 form,
the crystallographic packing symmetry of the P3121 form (center) and the analogous packing symmetry of the C2 form (right).
revealed that the three forms had basically the same packing
arrangement of the PurE octamer particle. The packing arrangement
can be briefly described as the hexagonal closest packing of a 422
aggregate in a hexagonal arrangement. The particle fourfold axis is
parallel to the high-symmetry crystallographic axis in the trigonal and
hexagonal forms that coincides with the c* direction of the C2 cell
(Fig. 3). The center of the PurE octamer does not coincide with the
position of the high-symmetry axes. The perpendicular crystallo-
graphic dyads in the high-symmetry forms spaced by 30–60 corre-
spond to similar noncrystallographic twofolds in the C2 form in the
ab plane (Fig. 3). The combination of the particle symmetry and the
crystallographic symmetry also produces noncrystallographic dyads
at 15–45 intervals that are also apparent in the C2 form. It should be
mentioned that the C2 packing of this structure is different from that
observed by previous investigators and the VM values are also
different (1.9 versus 2.2 A˚3 Da1; Boyle et al., 2005). Based on our
preliminary analysis of the current refined structures, the different
crystal forms arise from the different extents of ordering of the
laboratory communications
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Figure 4
Quantitative analysis of the improvements in the diffraction pattern in relation to
r.h. (a) Mean I/(I) versus relative humidity for the apo crystals of PurE form B.
Open diamonds refer to full reflections and black squares refer to partials. An
optimum is seen at approximately 85% r.h. (b) As in (a) for crystals of PurE form C
soaked in 10% DMSO overnight. (c) Comparison of the diffraction quality, mean
I/(I), versus r.h. of PurE crystals (form A). Open circles refer to crystals soaked in
10% ethanol for 2 ovn. Black triangles refer to apo crystals. Mean I/(I) refers to
the hI/(I)i values for all reflections at the maximum [I/(I) > 2.0] resolution of
the diffraction pattern.
Figure 5
Effect on the diffraction pattern of changes in the relative humidity of crystals of
PurE after soaking for 1 ovn in 5% DMSO (form A). Arrows indicate the sequence
of the r.h. changes. The experiment was conducted with the FMS installed on the
in-house rotating anode as described in x2.2.3. The collage is made up of images
directly obtained from the FMS, in which the right-hand portion of the detector is
partly shaded by the mechanical jacket containing the airflow hoses (Kiefersauer et
al., 2000).
carboxy-terminal residues (Glu156-Gly157-Ser158-Glu159-Leu160-
Val161) of the subunits in the external contact areas of the octamer.
Further details will be provided in a future publication.
The similar packing arrangement described above and the corre-
sponding change in unit-cell parameters is reflected in similar solvent
contents and packing ratios for the three forms (Table 2). The crystal
symmetry that was most versatile from the viewpoint of plasticity for
variation of the humidity control turned out to be the hexagonal one
corresponding to forms B, C and D. We attribute this plasticity to the
presence of various types and amounts of PEG in the crystallization
mixture that do not interact specifically with the macromolecules in
the crystal as has been observed by other researchers (Bo¨ttcher et al.,
2011) and provide a ‘cushion’ for the subtle changes in the inter-
molecular contacts of the crystal. These PEG-containing forms were
the crystals that we have used most extensively for the optimization
of protocols designed to soak ligands into pre-grown apoenzyme
crystals. Except for form B, which grows at 0.3M sodium acetate, the
other two high-symmetry forms (forms C and D) grow at rather high
formate concentration (0.8M). Form E was found through systematic
screening of the precipitation diagram (also referred to as the phase
diagram), varying the protein concentration, the salt concentration
and the pH (Fig. 1). Although this crystal form belongs to the same
space group as the previously reported structure of B. anthracis (PDB
entry 1xmp) and was grown at high sodium formate concentrations,
the unit-cell parameters are different and the two crystal forms are
not isomorphous (a = 168.3, b = 76.5, c = 102.7 A˚,  = 96.7; see
Table 2). It should be noted that the clones used for the two different
protein preparations differed in the N-terminal His tags that were
used to facilitate protein purification (Boyle et al., 2005).
The initial working protocols to establish the starting r.h. of the
hexagonal crystals were those suggested in publications describing
the FMS instrument (Kiefersauer et al., 2000). Firstly, using our in-
house FMS we found that the hexagonal crystals of PurE were indeed
sensitive to the fine control of relative humidity and that the effects
were reproducible, and established that the optimum r.h. was near
85% (scale based on the instrument settings without absolute cali-
bration; Fig. 4a). Further experiments showed that the optimum r.h.
for the form A crystals was in the range 70–80% (Fig. 4c).
A critical factor in the diffraction quality of macromolecular
crystals soaked with active ligands (inhibitors, effectors, substrate
analogs etc.) is the perturbation of the native environment (i.e.
mother liquor) of the crystals. This is particularly true for compounds
that are poorly soluble in aqueous solutions, as is the case for the
majority of chemical entities of pharmaceutical interest (Bo¨ttcher et
al., 2011). The solvent of choice for the preparation of stock solutions
(100 mM) is DMSO and to a lesser extent ethanol. Macromolecular
crystals are typically very sensitive to low concentrations [5%(v/v)]
of these carrier solvents and the diffraction quality of the crystals
deteriorates very readily upon soaking.
We have systematically tested the effect of changes in the r.h. of
crystals that have been exposed to various concentrations of DMSO.
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Figure 7
Improvements of the diffraction pattern of crystals of formD after lowering the salt
concentration (sodium formate) from 0.8 to 0M and letting them equilibrate
overnight according to the protocols shown in Table 3. This experiment was
conducted on beamline BM14 (ESRF). Note that with the HC device there is no
blind area in the detector (as opposed to FMS; see x2, Fig. 5 versus Figs. 6 and 7).
Figure 6
Improvements of the diffraction pattern of crystals of form B after desalting (0.8M
to 50 mM sodium formate, 8 h, PEG constant). The initial r.h. was 85% and varied
counterclockwise as indicated. Other experiments varying the r.h. from 70%
clockwise also had an optimum at the higher r.h. (90%). This experiment was
conducted on beamline BM14 (ESRF) using the HC device (see x2).
The most significant results are summarized in Figs. 4 and 5. Fig. 5
visually presents the results of varying the relative humidity (90–
60%) of crystals of PurE (form A) after soaking for long exposures
(overnight in 10% DMSO). An optimum of the diffraction pattern
can be appreciated visually between 65 and 70%, while for form B the
optimum is centered near 80%. Quantitative analysis of these results
is presented in Fig. 4(b). The effect of ethanol soaking (2 ovn) on
crystals of form A is shown (Fig. 4c) compared with native apo PurE
crystals. In these experiments we have selected long (>8 h) soaking
times to illustrate the dramatic improvement in the quality and extent
of the diffraction pattern and also because these protocols maximize
the soaking time, which is an important factor for the soaking of weak
ligands. In other experiments with soaking times of a few hours
(1–4 h) crystal damage is not so severe and consequently the recovery
effect is less striking. Although it might be crystal-dependent, it
would appear that for long soaking times in ethanol the organic
solvent appears to enhance the diffraction quality and resilience of
these crystals upon changes in the relative humidity (Fig. 4c).
Also important in optimizing the soaking of ligands into crystals
grown in high salt is to explore the results of lowering the salt
concentration and determine whether it is possible to recover the
quality and extent of the diffraction patterns by changing the relative
humidity. Our observations demonstrated that it was possible to
improve the diffraction pattern of form B crystals soaked in lower salt
concentrations (50 mM) for 8 h (Fig. 6). Interestingly, the diffraction
pattern improved upon raising the r.h. of the crystals from 85 to 90%;
we never observed improvement on going to drier conditions (Figs. 6
and 7). The results were reproducible and it was possible to collect
complete data sets (60–80 for the high-symmetry crystals) at room
temperature (T = 297 K) from crystals adjusted directly to the
optimum r.h. (typically 96–97%; see below). Typical data-collection
statistics for these data sets were Rmerge ’ 0.07–0.08 with complete-
ness ranging from 72 to 98% for in-house experiments at a resolution
near 3 A˚. The values for data sets collected from frozen crystals at the
optimum r.h. were Rmerge ’ 0.048–0.083 and a completeness of 93–
99.9% at resolutions of 2.5–1.76 A˚ (Table 2). Given the experimental
facilities at the beamlines where the humidity-control instrument was
set up (ESRF, BM14), crystals were frozen at the optimum relative
humidity by simply dismounting them into the crystal containers
under liquid nitrogen using the existing sample exchangers (see x2).
In order to maximize the exposure of the crystals to possible
ligands at minimum salt concentration, we developed protocols that
combined progressive ‘desalting’ solutions with higher PEG con-
centrations to minimize crystal deterioration. Nonetheless, standard
extended soaks (1 ovn or 2 ovn) of excellent apoenzyme crystals used
in soaking solutions (see x2) routinely resulted in crystals that
diffracted to very low resolutions; typically 8–6 A˚ at best at the
reference 85% relative humidity of the unsoaked crystals. Thus, it was
surprising and gratifying to see that 10% changes in the relative
humidity (from 85 to 95%) restored the diffraction quality dramati-
cally (Fig. 7). The effect was also reproducible in several crystals to
the point that successive crystals from the same soaking conditions
were set up directly at the optimum relative humidity (Fig. 8) and
data sets were collected either at room temperature or cooled under
cryoconditions on the same or a different beamline.
Following the combined protocols (desalting plus ligand soaking)
described above, one can maximize the exposure of the crystals to
high ligand concentrations under low (or minimum) salt concentra-
tions; the resulting crystals also diffracted very poorly (8–7 A˚ reso-
lution). Once again, relatively similar changes (10%) in relative
humidity (85–95%) restored the diffraction quality of the crystals,
making them useful for data collection at room temperature (or
under cryoconditions) at resolutions ranging from 2.9 to 2.3 A˚
(respectively) and consequently providing conclusive structural data
as to the binding (or lack of binding) of the ligands. These data sets
are of sufficient quality to define the binding characteristics of the
laboratory communications
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Figure 8
Diffraction patterns of form D crystals pre-soaked according to the protocols described in Table 3 and adjusted directly (no r.h. optimization) to 96% r.h. (a) and (b)
correspond to ’ = 0 and ’ = 90 spindle settings, respectively. The long c-axis dimension is clearly appreciable with distinct fully resolved reflections. This experiment was
conducted with the HC device at room temperature on beamline BM14 (ESRF).
ligand and often are acceptable to establish binding modes in
mechanistic studies, hit validation or even series optimizations
(Table 2).
Currently, it is common practice in experiments involving soaking
of ligands into pre-grown apo crystals to use a ‘harvesting solution’
that is as close as possible to the mother liquor to prevent damage to
the crystals. Although this approach is reasonable to maintain the
integrity of the crystals and to retain their initial diffraction qualities,
our results suggest that in cases where the active sites are occupied by
precipitants (typically salts at high concentration) it would be
advantageous to first soak the crystals in lower salt solutions. The
crystals would initially diffract much more poorly, but this dete-
rioration can be compensated by changing the relative humidity of
the crystals and diffraction may successfully be restored. Alter-
natively, it may also be possible to soak the ligands in crystals grown
in lower salt concentrations; although they might not diffract as well,
the active sites could be more accessible to weak ligands. After
soaking or using suboptimal crystals, the quality of the diffraction
pattern could be restored by appropriate adjustment of the relative
humidity of the crystals.
Our findings can be summarized as follows: (i) using humidity
control it is possible to improve/optimize the diffraction quality of
crystals soaked with ligands/inhibitors, (ii) optimization of the rela-
tive humidity can compensate for the deterioration of the diffraction
pattern that is observed upon desalting crystals grown at high salt,
(iii) combining desalting protocols with PEG addition it is possible
to achieve very high concentrations of weak ligands (in the 5–10 mM
range) in soaking solutions and (iv) fine control of the relative
humidity of the crystals soaked under these conditions can com-
pensate for the deterioration of crystal diffraction and restore ‘high-
resolution’ diffraction of value for SBDD and FBDD.
Extensive exploration of the precipitation diagrams allowed us
to discover the monoclinic form E (C2) at lower salt concentration
(Fig. 1, Table 1), which represents a novel form and was also used for
soaking of ligands and changes in relative humidity. However, it was
not as suitable for room-temperature data collection because of its
low symmetry. Structural details of the refined structures of PurE and
the detailed solvent structures in the three different crystal lattices
described above will be presented elsewhere.
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